Singapore: Bluechiip, which has developed a unique temperature sensing and tracking solution initially for cryogenic sample management in the healthcare and life science industry, signed a strategic partnership agreement with Gentris.

The strategic partnership will be focused on expanding Gentris' service model to include temperature tracking services. In addition to signing a strategic partnership agreement, Gentris also signed up for Bluechiip's Early Adopter Program (EAP), which includes purchasing the trial bluechiip solution thereby assisting with the ongoing validation of the bluechiip system.

Mr Eric Hall, vice president, Gentris' Biorepository Operations, said: "We believe the bluechiip technology offers bioreposititories and bioresource laboratories significant value via its ability to sense sample level temperature. This capability will allow Gentris to track the temperature of individual samples from time of collection to analysis, which improves our ability to evaluate and control the integrity of client samples."

Mr L Scott Clark, Gentris' chief scientific officer, said that, "The ability to understand sample-level temperature changes and trends in temperature across sample collections throughout the process chain and specimen lifecycle over time will be extremely valuable. This will lead to enhanced annotation of pre-analytical variables and improved identification of analytical artifacts that may occur due to changes in sample integrity."

Ms Lisa Miranda, VP, strategy and business Development, Bluechip, said that, "As a former Bioresource Core Director, historical biobanker and advocate of evidence-based biobanking practice, I am confident of the value that the bluechiip technology offers to bioresources across all sectors. Previous pilot trials have been positive, comprehensive, robust and extremely promising."